scholarly article | Q13442814 |
P356 | DOI | 10.1186/1477-7525-8-129 |
P953 | full work available at URL | https://hqlo.biomedcentral.com/counter/pdf/10.1186/1477-7525-8-55 |
https://doi.org/10.1186/1477-7525-8-55 | ||
https://europepmc.org/articles/PMC2994799 | ||
https://europepmc.org/articles/PMC2994799?pdf=render | ||
https://link.springer.com/content/pdf/10.1186/1477-7525-8-129.pdf | ||
P932 | PMC publication ID | 2994799 |
P698 | PubMed publication ID | 21070628 |
P5875 | ResearchGate publication ID | 47754577 |
P2093 | author name string | Joachim Kugler | |
Sabine Twork | |||
Jörg Klewer | |||
Dieter Pöhlau | |||
Susanne Wiesmeth | |||
P2860 | cites work | Myasthenia gravis | Q21202960 |
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis | Q27713200 | ||
Myasthenia gravis | Q29396951 | ||
Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis | Q30446611 | ||
Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis | Q74331643 | ||
Self-reported Pain Affects Quality of Life in Myasthenia Gravis | Q82947867 | ||
Myasthenia gravis (MG): epidemiological data and prognostic factors | Q30883242 | ||
Myasthenia gravis with ocular involvement in older patients. | Q32066428 | ||
Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America | Q33909223 | ||
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases | Q33946584 | ||
Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology | Q33966346 | ||
Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis | Q33979746 | ||
Current and future standards in treatment of myasthenia gravis | Q34014734 | ||
Myasthenia gravis and Lambert-Eaton syndrome. | Q34557111 | ||
Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis. | Q35455306 | ||
Intravenous immunoglobulin in autoimmune neuromuscular diseases | Q35776725 | ||
Mood and anxiety disorders in patients with myasthenia gravis: aetiology, diagnosis and treatment | Q36830148 | ||
Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients | Q40002773 | ||
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis. | Q40099380 | ||
Muscle autoantibodies in subgroups of myasthenia gravis patients | Q40757160 | ||
Behavior analysis in myasthenia gravis | Q42155914 | ||
Long-term outcome and quality of life after open and thoracoscopic thymectomy for myasthenia gravis: analysis of 131 patients | Q42646259 | ||
Treatment of refractory myasthenia: "rebooting" with high-dose cyclophosphamide | Q44267952 | ||
A limited epidemiological study of seropositive myasthenia gravis in Tayside. | Q44343959 | ||
Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy | Q44545095 | ||
Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability | Q44669253 | ||
Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis | Q44672927 | ||
Myasthenia gravis in the elderly: Is it different? | Q45009680 | ||
[Myasthenia gravis and myasthenic syndromes]. | Q45927118 | ||
Disease-specific measure of quality of life for myasthenia gravis | Q46433849 | ||
Varieties of healing. 2: a taxonomy of unconventional healing practices | Q47615262 | ||
Correlates of quality of life among persons with multiple sclerosis | Q48568973 | ||
Exacerbation of a case of myasthenia gravis during therapeutic electric stimulation | Q48973161 | ||
The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study | Q49091165 | ||
Correlation between regional myasthenic weakness and mental aspects of quality of life. | Q50772429 | ||
Quality of life and well-being of patients with myasthenia gravis. | Q51068492 | ||
Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. | Q51134840 | ||
Determinants of cognitive impairment in elderly myasthenia gravis patients. | Q51890262 | ||
Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. | Q51958620 | ||
Cognitive dysfunction in individuals with myasthenia gravis. | Q52163626 | ||
[The SF-36 in the Federal Health Survey--description of a current normal sample] | Q52973363 | ||
Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. | Q53110551 | ||
Coping with myasthenia gravis and implications for psychotherapy. | Q53389545 | ||
[Coping with illness in myasthenia gravis] | Q54230091 | ||
Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis | Q60460361 | ||
Myasthenia gravis | Q60594487 | ||
Quality of life in patients with myasthenia gravis | Q62380213 | ||
Myasthenia gravis in the frontier of psychiatric diagnosis | Q67937705 | ||
Physical training effects in myasthenia gravis | Q72606774 | ||
Myasthenia gravis: a retrospective study comparing thymectomy to conservative treatment | Q73412984 | ||
Inline skating as a possible cause of consecutive bilateral vertebral artery dissection | Q73413001 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | myasthenia gravis | Q8285 |
quality of life | Q13100823 | ||
P304 | page(s) | 129 | |
P577 | publication date | 2010-11-11 | |
P1433 | published in | Health and Quality of Life Outcomes | Q15757755 |
P1476 | title | Quality of life and life circumstances in German myasthenia gravis patients | |
P478 | volume | 8 |
Q33638581 | A conceptual framework for evaluating impairments in myasthenia gravis |
Q35908237 | An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts |
Q48404090 | Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). |
Q57492183 | Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence |
Q40857202 | Effectiveness of teleassistance at improving quality of life in people with neuromuscular diseases. |
Q93066604 | Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis |
Q83524513 | Evaluation of a scale of patient-reported outcomes for the assessment of myasthenia gravis patients in China |
Q50954499 | Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. |
Q92337548 | Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life |
Q41628131 | Impact of myasthenia gravis on family planning: How do women with myasthenia gravis decide and why? |
Q38812574 | Is there any relationship between quality of life and polysomnographically detected sleep parameters/disorders in stable myasthenia gravis? |
Q36195417 | Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997-2011: a Danish nationwide cohort study |
Q91931025 | Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome |
Q50083299 | Ptosis Surgery in Patients with Myasthenia Gravis: A Useful Adjunct to Medical Therapy |
Q47695979 | Quality of life in 188 patients with myasthenia gravis in China |
Q37681359 | Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study |
Q48414932 | The MG-QOL15 Japanese version: validation and associations with clinical factors |
Q47652247 | The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial |
Search more.